Establish stable cell line to express M2 ion channel of influenza a virus H5N1

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 11, 2008, Pages 1902-1906

  Sun, Juanjuan ^a,b   Li, Chufang ^a   Xu, Wei ^a   Li, Zhiyuan ^a,c   Liu, Jinsong ^a   Chen, Ling ^a,b  

^a GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Induced by tetracycline; Influenza virus; M2 ion channel

Indexed keywords

INFLUENZA A VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

ION CHANNEL; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; HUMAN; INFLUENZA VIRUS A H5N1; KIDNEY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATCH CLAMP;

BASE SEQUENCE; CELL LINE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; ION CHANNELS; KIDNEY; MOLECULAR SEQUENCE DATA; PATCH-CLAMP TECHNIQUES; VIRAL MATRIX PROTEINS;

EID: 70349334109     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Nicholson KG, Wood JM, Maria Z. Influenza. Lancet, 2003, 362: 1733-1745.
2. Beigel JH. Avian influenza a (H5N1) infection in humans. N Engl J Med, 2005, 353: 1374-1385.
3. Takeda M, Pekosz A, Shuck K, et al. Influenza A Virus M2 ion channel activity is essential for efficient replication in tissue culture. J Virol, 2002, 76(3): 1391-1399.
4. De Clercq E. Strategies in the design of antiviral drugs. Nature Rev Drug Discov, 2002, 1: 13-25.
5. De Clercq E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov, 2006, 5(12): 1015-1025.
6. Ilyushina NA, Govorkova EA, Webster RG. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology, 2005, 341(1): 102-106.
7. Weinstock DM, Zuccotti G. Adamantane resistance in Influenza A. J Am Med Assoc, , 2006, 22, 295(8): 934-936.
8. He G, Qiao J, Dong C, He C, et al. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res, 2008, 77(1): 72-76.
9. Hurt AC, Selleck P, Komadina N, et al. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res, 2007; 73(3): 228-231. Epub 2006 Nov 10.
10. Pinto LH, Lambb RA. Influenza virus proton channels. Photochem Photobiol Sci, 2006, 5(6): 629-632.
11. Ramakrishna L, Anand KK, Mohankumar KM, et al. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J Virol, 2004, 78(17): 9174-9189.
12. Mechold U, Gilbert C, Ogryzko V. Codon optimization of the BirA enzyme gene leads to higher expression and an improved efficiency of biotinylation of targetproteins in mammalian cells. J Biotechnol, 2005, 116: 245-249.
13. Bandyopadhyay B, Li GB, Yin HS, et al. Tau aggregation and toxicity in a cell culture model of tauopathy. J Biol Chem, 2007, 282(22): 16454-16464.
14. Wang C, Takeuchi K, Pinto LH, et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol, 1993, 67(9): 5585-5594.
15. Li Z, Migita K, Samways DS, et al. Gain and loss of channel function by alanine substitutions in the transmembrane segments of the rat ATP-gated P2X2 receptor. J Neurosci, 2004, 24(33): 7378-7386.
16. Holsinger LJ, Shaughnessy MA, MickoA, et al. Analysis of the posttranslational modifications of the influenza virus M2 protein. J Virol, 1995, 69(2): 1219-1225.
17. Veit M, Klenk HD, Kendal A, et al. The M2 protein of influenza a virus is acylated. J Gen Virol, 1991, 72: 1461-1465.
18. Black RA, Rota PA, Gorodkova N, et al. Antibody response to the M2 protein of influenza A virus expressed in insect cells. J Gen Virol, 1993, 74(Pt 1): 143-146.
19. Guinea R, Carrasco L. Influenza virus M2 protein modifies membrane permeability in E. coli cells. FEBS Lett, 1994, 343(3): 242-246.
20. Kurtz S, Luo G, Hahnenberger KM, et al. Growth impairment resulting from expression of influenza virus M2 protein in Saccharomyces cerevisiae: identification of a novel inhibitor of influenza virus. Antimicrob Agents Chemother, 1995, 39(10): 2204-2209.
21. Giffin K, Rader RK, Marino MH, et al. Novel assay for the influenza virus M2 channel activity. FEBS Lett, 1995, 357(3): 269-274.
22. Ilyinskii PO, Gabai VL, Sunyaev SR, et al. Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity. Cell Cycle, 2007, 6(16): 2043-2047.